ClinicalTrials.gg
RecruitingNCT06469918Updated Oct 7, 2025

The Co-Op @ HeartWorks

An observational study in Congenital Heart Disease, sponsored by HeartWorks, Inc.. Recruiting at 1 site in United States. Open to participants aged 0 Years and older. Per ClinicalTrials.gov, last updated 2025-10-07.

Sponsored by HeartWorks, Inc. · Observational

How we know

From the registry’s dates

  • Started Jan 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
500
Ages
0 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 356 studies in Heart Defects, Congenital with a site in United States — 67 open to participants now, 87 under way, 4 of them phase 3. Heart Defects, Congenital · United States.

Planned enrollment
35th of 167
500 · median 72
Started
2024
with 15 others
Observational
170 of 356
36 open now
Primary completion
2050-01
later than 84 of 86 live
Registered
322nd of 356
by date

Among the 356 studies in Heart Defects, Congenital with a site in United States, this one is the 35th largest by planned enrollment of the 167 observational ones that give a count, is one of 16 that started in 2024, is one of 170 observational ones, reaches primary completion later than 84 of the 86 other live ones, and was the 322nd registered.

Heart Defects, Congenital

992 studies on the registry are indexed under Heart Defects, Congenital; 252 are open to participants now.

Browse Heart Defects, Congenital studies →

Open to participants now

67 of the 356 studies in Heart Defects, Congenital with a site in United States are open now. Recruiting first, the newest first:

62 more — sign in →

All 67 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 156 Heart Defects, Congenital studies recruiting now, 69 (44%) set no upper age limit and 79 (51%) stop at 75 or younger; 112 take children under 18; 25 take healthy volunteers.

This study: 0 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 356 studies in Heart Defects, Congenital with a site in United States, or all of them as a file.
02

Study summary

This protocol is a research study involving human subjects diagnosed with Congenital Heart Defects/Disease (CHD). The Co-Op @ HeartWorks is a cooperative between the research platform at HeartWorks and members of the CHD community. Individuals choosing to participate will be referred to as 'members' of the co-op. This study aims to create a database of members medical journey data to inform future clinical innovation and design of clinical trials which address the needs of the members. The knowledge generated from this study will help advance the care of CHD patients through the deliberate action of The Co-Op @ HeartWorks members. Unlike a traditional disease registry, the members of The Co-Op @ HeartWorks will actively inform and contribute to the future studies affecting their health.

03

Conditions studied

  • Congenital Heart Disease

Keywords

  • HLHS
  • congenital heart defect
  • CHD
  • Hypoplastic left heart syndrome
04

Who can participate

Ages eligible
0 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Human subjects with congenital heart disease

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult with a congenital heart defects/disease
  • Caregiver of a minor with a congenital heart defect/disease
  • Authorized family member of a now deceased person with congenital heart defect/disease

Exclusion criteria

Exclusion Criteria:

- Not having a congenital heart defect/disease

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
500 participants (estimated)
Target follow-up
25 Years
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Registry of individuals with CHD to plan and recruit for future interventional trials in Congenital Heart Defects/Disease

    Time frame: 25 years

07

Study locations

1 of 1 sites recruiting
  • HeartWorks, Inc.
    Rochester, Minnesota 55901, United States
    Recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Informed consent form

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Jan 2050, 311 months after the start.

Of 178 non-industry observational studies under Heart Defects, Congenital, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 83. This study's planned 311 months is above that.

Counting every sponsor, half of 185 studies reached it within 44 months; a quarter within 17 and three quarters within 83.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 14, 2024
First posted
Jun 24, 2024
StartActual
Jan 24, 2024
Primary completionEst.
Jan 1, 2050
CompletionEst.
Jan 1, 2050
Last update
Oct 7, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 7, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06469918
Lead sponsor
HeartWorks, Inc.
Responsible party
Sponsor
First posted
Jun 24, 2024
Start date
Jan 24, 2024
Primary completion
Jan 1, 2050 (estimated)
Completion
Jan 1, 2050 (estimated)
Last update
Oct 7, 2025

Study contacts

Adam Armstrong
Contact
adam@webuildhearts.org
(507) 577-1764

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion